This session of CVI Interventional Octagon webinar series is a Peripheral/Endovascular session on the topic of Carotid. For this session, our esteemed panel will be presenting their own most interesting and challenging cases. This CME webinar is complimentary, although registration is required.
Agenda
- CREST II, Redefining Carotid Revascularization in 2026! (10 min), Thomas Brott, MD
- Technical Aspect of TF Carotid Artery Stenting (10 min), Herbert Aronow, MD
- In the CREST II Era, Which Patients Should Still Get CEA? (10 min), Alpesh Shah, MD
- Role of TCAR in Setting of CREST II and CEA (10 min), Bradley Grimsley, MD
Moderators:
Subhash Banerjee, MD
Baylor Heart and Vascular Hospital
Mehdi Shishehbor, DO, MPH, PhD
University Hospitals Harrington Heart & Vascular Institute
Faculty
Herbert Aronow, MD, MPH
Henry Ford Health
Thomas Brott, MD
Mayo Clinic
Bradley Grimsley, MD
Baylor Scott & White Health
Alpesh Shah, MD
Houston Methodist
Learning Objectives
- Describe how CREST II findings are influencing current carotid revascularization strategies.
- Compare patient selection and clinical considerations for CEA, transfemoral carotid stenting, and TCAR.
- Apply procedural best practices to support optimal outcomes in carotid artery interventions.
This activity has been approved for AMA PRA Category 1.0 Credit™.
Interventional Octagon is made possible by generous grants from
Abbott, Boston Scientific Corporation, Cordis and Medtronic.
